stella
beta
Evaluation of HER2DX Assay on Treatment Decisions in Patients With Early Stage HER2+ Breast Cancer: the HER2BREASTDX — Stella
Recruiting
Back to Breast Cancer Early Stage Breast Cancer (Stage 1-3) trials
Trial locations
(1 site)
Italy
Istituto Europeo di Oncologia, Milan, Italy
View full record on ClinicalTrials.gov